A Retrospective Study of the Impact of 21-Gene Recurrence Score Assay on Treatment Choice in Node Positive Micrometastatic Breast Cancer

To assess clinical utility of the 21-gene assay (Oncotype DX® Recurrence Score®), we determined whether women with HER2(−)/ER+ pN1mi breast cancer with low (<18) Recurrence Scores results are given adjuvant chemotherapy in a lower proportion than those with high scores (≥31). This was a multicent...

Full description

Saved in:
Bibliographic Details
Main Authors: Thomas G. Frazier (Author), Kevin R. Fox (Author), J. Stanley Smith (Author), Christine Laronga (Author), Anita McSwain (Author), Devchand Paul (Author), Michael Schultz (Author), Joseph Stilwill (Author), Christine Teal (Author), Tracey Weisberg (Author), Judith F. Vacchino (Author), Amy P. Sing (Author), Dasha Cherepanov (Author), Wendy Hsiao (Author), Eunice Chang (Author), Michael S. Broder (Author)
Format: Book
Published: MDPI AG, 2015-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available